Medical Imaging AI
Revolutionizing
- cancer patient diagnosis, treatment and survival
- cancer drug development
FREDRIK BRAG, CEO & FOUNDER
MEDIAN TECHNOLOGIES
TD COWEN 44TH HEALTH CARE CONFERENCE
BOSTON, MA, USA
MARCH 4-6, 2024
Applying AI and computer vision, we help conquer cancer and other life-threatening diseases by extracting powerful clinical insights from medical images.
Our people | 260+ highly qualified professionals in the |
US, Europe and China, 25+ nationalities | |
(As of Dec. 31, 2023). | |
Our growth | Powered by proprietary AI, computer |
vision and signal processing technologies, | |
strong KOL connections, and medical, | |
scientific, technology partnerships. | |
With eyonis , our AI/ML tech-based | |
suite of software as medical devices | |
(SaMD), we help enable clinicians to | |
diagnose patients earlier. | |
Imaging | Our iCRO imaging solutions and advanced |
Lab | Imaging Lab offer help our 80+ |
biopharma clients drive their oncology | |
clinical studies toward successful | |
approval, using AI-driven image insights. | |
Imaging AI for Cancer
3 | mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA |
Imaging AI for Patient Care
Imaging AI for Patient Care is revolutionizing preventive care and will help eradicate cancer by:
- Fueling the emergence of early diagnosis,
- Allowing predictive and personalized treatment plans,
- Leading to better patient outcomes.
4 | mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA |
AI in Drug Discovery & Development
Based on data-driven insights, AI technologies will enable personalized treatments for better outcome:
- By decreasing the number of compounds subsequently tested in pre-clinical and clinical studies (clinical trials),
- By enabling personalized treatments,
- By helping the biopharma industry control at best the drug development process, time and costs.
5 | mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA |
The Global Cancer Burden
Imaging AI will have the biggest impact ever on cancer care
6 | mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA |
Facts & Trends about Cancer
Financial burden of
1 cancer in the US was $210bn in 2020 and projected to exceed $245bn by 2030 [1].
The cost for bringing a
4 cancer drug to market is $2.7Bn [2] during 12 years. With AI it could be a fraction of the cost & time
97% of cancer care
2 money goes for treatment of sick patients vs 3% for preventive care.
5 | The cost of developing a |
new AI based imaging |
diagnostic test for cancer is approx. $40m.
3
6
Most Stage 1 cancer can be cured and can now be identified with Imaging AI.
Most cancer drugs could become curative through personalized treatments. Viral Therapy, vaccine & immune therapy
Sources: | |||
[1] | American Association for Cancer Research | ||
7 | mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA | [2] | Deloitte Report - January 2023 |
US Cancer Death Rates Evolution over the Long-run
Early diagnosis and lifestyles changes have the biggest impact on cancer death rates:
• Lung and stomach cancer death rates decrease, driven by lifestyles changes.
• Prostate, colorectal and breast cancer rates decrease, driven by early diagnosis and screening programs.
8 | mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA |
AI Breakthroughs Applied to Medical Imaging Mark the Beginning of a New Era for Cancer Management
Applying AI and computer vision technologies help conquer cancer by extracting powerful clinical insights from medical images.
1| | 2| | 3| | Guide health |
professionals in | |||
Diagnose | their clinical | ||
cancer earlier | Personalize | ||
decision-making | |||
and more | treatments | ||
with data- | |||
accurately | driven clinical |
insights |
9 | mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA |
Median Technologies Leverages AI Technologies to Bring More Value to Medical Images all along the Patient Journey
Adding more | Generating more | Providing more |
AI-driven data | ||
value to oncology | accurate | |
for oncology | ||
trials | AI-driven diagnosis | |
drug development | ||
• | Extract drug efficacy data | • | Select early-stage patient | • | Develop noninvasive, early- | ||
• | Streamline the clinical | • | Discover predictive | stage diagnostic solutions | |||
process | imaging biomarkers | • | Market SaMDs for routine | ||||
clinical use | |||||||
• | Develop companion diagnostics |
10 mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Median Technologies SA published this content on 07 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 March 2024 18:12:09 UTC.